Use of Post-mortem Brain Tissue in Investigations of Obsessive- Compulsive Disorder: A Systematic Review


Cite item

Full Text

Abstract

Background:Post-mortem examination of the brain is a key strategy to increase our understanding of the neurobiology of mental disorders. While extensive post-mortem research has been undertaken on some mental disorders, others appear to have been relatively neglected.

Objective:The objective of the study was to conduct a systematic review of post-mortem research on obsessive-compulsive disorder (OCD).

Methods:A systematic review was performed in accordance with PRISMA guidelines to provide an overview of quantitative, qualitative, or mixed methods primary research studies on OCD. Search platforms included NCBI Pubmed, SCOPUS, and Web of Science.

Results:A total of 52 publications were found, and after the removal of works not meeting the inclusion criteria, six (6) peer-reviewed publications remained. These post-mortem studies have provided data on DNA methylation, cellular and molecular alterations, and gene expression profiling in brain areas associated with OCD.

Discussion and Conclusion:Included studies highlight the potential value of post-mortem brains from well-characterized individuals with OCD and suggest the need for additional work in this area.

About the authors

Christine Lochner

SA MRC Unit on Risk and Resilience in Mental Disorders, Department of Psychiatry, University of Stellenbosch

Author for correspondence.
Email: info@benthamscience.net

Petrus Naudé

Department of Psychiatry and Mental Health & Neuroscience Institute, University of Cape Town

Email: info@benthamscience.net

Dan Stein

SA MRC Unit on Risk and Resilience in Mental Disorders, Department of Psychiatry and Mental Health & Neuroscience Institute, University of Cape Town

Email: info@benthamscience.net

References

  1. Phillips, K.A.; Stein, D.J.; Rauch, S.L.; Hollander, E.; Fallon, B.A.; Barsky, A.; Fineberg, N.; Mataix-Cols, D.; Ferrão, Y.A.; Saxena, S.; Wilhelm, S.; Kelly, M.M.; Clark, L.A.; Pinto, A.; Bienvenu, O.J.; Farrow, J.; Leckman, J. Should an obsessive-compulsive spectrum grouping of disorders be included in DSM-V? Depress. Anxiety, 2010, 27(6), 528-555. doi: 10.1002/da.20705 PMID: 20533367
  2. Stein, D.J.; Kogan, C.S.; Atmaca, M.; Fineberg, N.A.; Fontenelle, L.F.; Grant, J.E.; Matsunaga, H.; Reddy, Y.C.J.; Simpson, H.B.; Thomsen, P.H.; van den Heuvel, O.A.; Veale, D.; Woods, D.W.; Reed, G.M. The classification of obsessive-compulsive and related disorders in the ICD-11. J. Affect. Disord., 2016, 190, 663-674. doi: 10.1016/j.jad.2015.10.061 PMID: 26590514
  3. Stein, D.J.; Craske, M.G.; Friedman, M.J.; Phillips, K.A. Meta-structure issues for the DSM-5: how do anxiety disorders, obsessive-compulsive and related disorders, post-traumatic disorders, and dissociative disorders fit together? Curr. Psychiatry Rep., 2011, 13(4), 248-250. doi: 10.1007/s11920-011-0207-1 PMID: 21603904
  4. Ruscio, A.M.; Stein, D.J.; Chiu, W.T.; Kessler, R.C. The epidemiology of obsessive-compulsive disorder in the National Comorbidity Survey Replication. Mol. Psychiatry, 2010, 15(1), 53-63. doi: 10.1038/mp.2008.94 PMID: 18725912
  5. Fontenelle, L.F.; Mendlowicz, M.V.; Versiani, M. The descriptive epidemiology of obsessive–compulsive disorder. Prog. Neuropsychopharmacol. Biol. Psychiatry, 2006, 30(3), 327-337. doi: 10.1016/j.pnpbp.2005.11.001 PMID: 16412548
  6. Fawcett, E.J.; Power, H.; Fawcett, J.M. Women are at greater risk of OCD than men. J. Clin. Psychiatry, 2020, 81(4), 19r13085. doi: 10.4088/JCP.19r13085 PMID: 32603559
  7. Murray, C.J.L.; Lopez, A.D. Evidence-based health policy--lessons from the Global Burden of Disease Study. Science, 1996, 274(5288), 740-743. doi: 10.1126/science.274.5288.740 PMID: 8966556
  8. World Health Organization. Depression and other common mental disorders: global health estimates; World Health Organization, 2017.
  9. World Health Organization. The global burden of disease 2004 update; World Health Organization, 2008, p. 146p.
  10. Simpson, H.B.; Huppert, J.D.; Petkova, E.; Foa, E.B.; Liebowitz, M.R. Response versus remission in obsessive-compulsive disorder. J. Clin. Psychiatry, 2006, 67(2), 269-276. doi: 10.4088/JCP.v67n0214 PMID: 16566623
  11. Pallanti, S.; Quercioli, L. Treatment-refractory obsessive-compulsive disorder: Methodological issues, operational definitions and therapeutic lines. Prog. Neuropsychopharmacol. Biol. Psychiatry, 2006, 30(3), 400-412. doi: 10.1016/j.pnpbp.2005.11.028 PMID: 16503369
  12. Greist, J.H.; Bandelow, B.; Hollander, E.; Marazziti, D.; Montgomery, S.A.; Nutt, D.J.; Okasha, A.; Swinson, R.P.; Zohar, J. WCA recommendations for the long-term treatment of obsessive-compulsive disorder in adults. CNS Spectr., 2003, 8(S1), 7-16. doi: 10.1017/S1092852900006908 PMID: 14767394
  13. Middleton, R.; Wheaton, M.G.; Kayser, R.S.H. Treatment resistance in obsessive-compulsive disorder. In: Treatment Resistance in Psychiatry; Yk, K., Ed.; Springer Singapore: Singapore, 2019. doi: 10.1007/978-981-10-4358-1_11
  14. Simpson, H.B.; Hezel, D.M. Exposure and response prevention for obsessive-compulsive disorder: A review and new directions. Indian J. Psychiatry, 2019, 61(7)(Suppl. 1), 85. doi: 10.4103/psychiatry.IndianJPsychiatry_516_18 PMID: 30745681
  15. Wolmarans, D.W.; Scheepers, I.M.; Stein, D.J.; Harvey, B.H. Peromyscus maniculatus bairdii as a naturalistic mammalian model of obsessive-compulsive disorder: current status and future challenges. Metab. Brain Dis., 2018, 33(2), 443-455. doi: 10.1007/s11011-017-0161-7 PMID: 29214602
  16. Szechtman, H; Ahmari, SE; Beninger, RJ; Eilam, D; Harvey, BH; Edemann-Callesen, H Obsessive-compulsive disorder: Insights from animal models. Neurosci Biobehav Rev, 2017, 76(Pt B), 254-79.
  17. Ahmari, S.E.; Spellman, T.; Douglass, N.L.; Kheirbek, M.A.; Simpson, H.B.; Deisseroth, K.; Gordon, J.A.; Hen, R. Repeated cortico-striatal stimulation generates persistent OCD-like behavior. Science, 2013, 340(6137), 1234-1239. doi: 10.1126/science.1234733 PMID: 23744948
  18. Andersen, S.L.; Greene-Colozzi, E.A.; Sonntag, K.C. A novel, multiple symptom model of obsessive-compulsive-like behaviors in animals. Biol. Psychiatry, 2010, 68(8), 741-747. doi: 10.1016/j.biopsych.2010.05.011 PMID: 20619828
  19. Burguière, E.; Monteiro, P.; Feng, G.; Graybiel, A.M. Optogenetic stimulation of lateral orbitofronto-striatal pathway suppresses compulsive behaviors. Science, 2013, 340(6137), 1243-1246. doi: 10.1126/science.1232380 PMID: 23744950
  20. Camilla d’Angelo, L.S.; Eagle, D.M.; Grant, J.E.; Fineberg, N.A.; Robbins, T.W.; Chamberlain, S.R. Animal models of obsessive-compulsive spectrum disorders. CNS Spectr., 2014, 19(1), 28-49. doi: 10.1017/S1092852913000564 PMID: 24093759
  21. Joel, D.; Klavir, O. The effects of temporary inactivation of the orbital cortex in the signal attenuation rat model of obsessive compulsive disorder. Behav. Neurosci., 2006, 120(4), 976-983. doi: 10.1037/0735-7044.120.4.976 PMID: 16893303
  22. Korff, S.; Stein, D.J.; Harvey, B.H. Stereotypic behaviour in the deer mouse: pharmacological validation and relevance for obsessive compulsive disorder. Prog. Neuropsychopharmacol. Biol. Psychiatry, 2008, 32(2), 348-355. doi: 10.1016/j.pnpbp.2007.08.032 PMID: 17888556
  23. Shmelkov, S.V.; Hormigo, A.; Jing, D.; Proenca, C.C.; Bath, K.G.; Milde, T.; Shmelkov, E.; Kushner, J.S.; Baljevic, M.; Dincheva, I.; Murphy, A.J.; Valenzuela, D.M.; Gale, N.W.; Yancopoulos, G.D.; Ninan, I.; Lee, F.S.; Rafii, S. Slitrk5 deficiency impairs corticostriatal circuitry and leads to obsessive-compulsive–like behaviors in mice. Nat. Med., 2010, 16(5), 598-602. doi: 10.1038/nm.2125 PMID: 20418887
  24. Welch, J.M.; Lu, J.; Rodriguiz, R.M.; Trotta, N.C.; Peca, J.; Ding, J.D.; Feliciano, C.; Chen, M.; Adams, J.P.; Luo, J.; Dudek, S.M.; Weinberg, R.J.; Calakos, N.; Wetsel, W.C.; Feng, G. Cortico-striatal synaptic defects and OCD-like behaviours in Sapap3-mutant mice. Nature, 2007, 448(7156), 894-900. doi: 10.1038/nature06104 PMID: 17713528
  25. Wood, J.; LaPalombara, Z.; Ahmari, S.E. Monoamine abnormalities in the SAPAP3 knockout model of obsessive-compulsive disorder-related behaviour. Philos. Trans. R. Soc. Lond. B Biol. Sci., 2018, 373(1742), 20170023. doi: 10.1098/rstb.2017.0023 PMID: 29352023
  26. Ahmari, S.E. Using mice to model Obsessive Compulsive Disorder: From genes to circuits. Neuroscience, 2016, 321, 121-137. doi: 10.1016/j.neuroscience.2015.11.009 PMID: 26562431
  27. Chamberlain, B.L.; Ahmari, S.E. Animal Models for OCD Research. In: Current Topics in Behavioral Neurosciences; Fineberg, N.A.; Robbins, T.W., Eds.; Springer International Publishing: Cham, 2021; pp. 55-96. Internet
  28. Fernandez, T.V.; Leckman, J.F.; Pittenger, C. Genetic susceptibility in obsessive-compulsive disorder. Handb. Clin. Neurol., 2018, 148, 767-781. doi: 10.1016/B978-0-444-64076-5.00049-1 PMID: 29478613
  29. Mataix-Cols, D.; Boman, M.; Monzani, B.; Rück, C.; Serlachius, E.; Långström, N.; Lichtenstein, P. Population-based, multigenerational family clustering study of obsessive-compulsive disorder. JAMA Psychiatry, 2013, 70(7), 709-717. doi: 10.1001/jamapsychiatry.2013.3 PMID: 23699935
  30. Brander, G.; Kuja-Halkola, R.; Rosenqvist, M.A.; Rück, C.; Serlachius, E.; Fernández de la Cruz, L.; Lichtenstein, P.; Crowley, J.J.; Larsson, H.; Mataix-Cols, D. A population-based family clustering study of tic-related obsessive-compulsive disorder. Mol. Psychiatry, 2021, 26(4), 1224-1233. doi: 10.1038/s41380-019-0532-z PMID: 31616041
  31. Pauls, D.L.; Abramovitch, A.; Rauch, S.L.; Geller, D.A. Obsessive–compulsive disorder: an integrative genetic and neurobiological perspective. Nat. Rev. Neurosci., 2014, 15(6), 410-424. doi: 10.1038/nrn3746 PMID: 24840803
  32. Chakrabarty, K.; Bhattacharyya, S.; Christopher, R.; Khanna, S. Glutamatergic dysfunction in OCD. Neuropsychopharmacology, 2005, 30(9), 1735-1740.
  33. Kariuki-Nyuthe, C.; Gomez-Mancilla, B.; Stein, D.J. Obsessive compulsive disorder and the glutamatergic system. Curr. Opin. Psychiatry, 2014, 27(1), 32-37. doi: 10.1097/YCO.0000000000000017 PMID: 24270485
  34. Wu, K.; Hanna, G.L.; Rosenberg, D.R.; Arnold, P.D. The role of glutamate signaling in the pathogenesis and treatment of obsessive–compulsive disorder. Pharmacol. Biochem. Behav., 2012, 100(4), 726-735. doi: 10.1016/j.pbb.2011.10.007 PMID: 22024159
  35. Wu, K.; Hanna, G.L.; Easter, P.; Kennedy, J.L.; Rosenberg, D.R.; Arnold, P.D. Glutamate system genes and brain volume alterations in pediatric obsessive-compulsive disorder: A preliminary study. Psychiatry Res. Neuroimaging, 2013, 211(3), 214-220. doi: 10.1016/j.pscychresns.2012.07.003 PMID: 23154099
  36. Arnold, P.D.; Askland, K.D.; Barlassina, C.; Bellodi, L.; Bienvenu, O.J.; Black, D. Revealing the complex genetic architecture of obsessive–compulsive disorder using meta-analysis. Mol. Psychiatry, 2018, 23(5), 1181-1188. doi: 10.1038/mp.2017.154 PMID: 28761083
  37. Mahjani, B.; Bey, K.; Boberg, J.; Burton, C. Genetics of obsessive-compulsive disorder. Psychol. Med., 2021, 51(13), 2247-2259. doi: 10.1017/S0033291721001744 PMID: 34030745
  38. Pauls, D.L. The genetics of obsessive-compulsive disorder: a review. Dialogues Clin. Neurosci., 2010, 12(2), 149-163. doi: 10.31887/DCNS.2010.12.2/dpauls PMID: 20623920
  39. Mataix-Cols, D.; Wooderson, S.; Lawrence, N.; Brammer, M.J.; Speckens, A.; Phillips, M.L. Distinct neural correlates of washing, checking, and hoarding symptom dimensions in obsessive-compulsive disorder. Arch. Gen. Psychiatry, 2004, 61(6), 564-576. doi: 10.1001/archpsyc.61.6.564 PMID: 15184236
  40. Bandelow, B.; Baldwin, D.; Abelli, M.; Bolea-Alamanac, B.; Bourin, M.; Chamberlain, S.R. Biological markers for anxiety disorders, OCD and PTSD: A consensus statement. Part II: Neurochemistry, neurophysiology and neurocognition. World J. Biol. Psychiatry, 2017, 18(3), 162-214.
  41. Bhattacharyya, S.; Khanna, S.; Chakrabarty, K.; Mahadevan, A.; Christopher, R.; Shankar, S.K. Anti-brain autoantibodies and altered excitatory neurotransmitters in obsessive-compulsive disorder. Neuropsychopharmacology, 2009, 34(12), 2489-2496.
  42. Guo, H.R.; Huang, B.L.; Wang, Y.L.; Zhang, Y.Y.; Ma, Q.G.; Lv, P.P.; Ren, Y.M. Effect of escitalopram on serum GDNF and BDNF levels and 5-HT level of brain tissue of obsessive-compulsive disorder rats. Cell. Mol. Neurobiol., 2020, 40(6), 991-997. doi: 10.1007/s10571-020-00788-4 PMID: 31927718
  43. Lustberg, D.; Iannitelli, A.F.; Tillage, R.P.; Pruitt, M.; Liles, L.C.; Weinshenker, D. Central norepinephrine transmission is required for stress-induced repetitive behavior in two rodent models of obsessive-compulsive disorder. Psychopharmacology (Berl.), 2020, 237(7), 1973-1987. doi: 10.1007/s00213-020-05512-0 PMID: 32313981
  44. Stein, D.J.; Costa, D.L.C.; Lochner, C.; Miguel, E.C.; Reddy, Y.C.J.; Shavitt, R.G.; van den Heuvel, O.A.; Simpson, H.B. Obsessive-compulsive disorder. Nat. Rev. Dis. Primers, 2019, 5(1), 52. doi: 10.1038/s41572-019-0102-3 PMID: 31371720
  45. van den Heuvel, O.A.; van Wingen, G.; Soriano-Mas, C.; Alonso, P.; Chamberlain, S.R.; Nakamae, T. Brain circuitry of compulsivity. Eur. Neuropsychopharmacol., 2016, 26(5), 810-827.
  46. Kwon, J.S.; Jang, J.H.; Choi, J.S.; Kang, D.H. Neuroimaging in obsessive–compulsive disorder. Expert Rev. Neurother., 2009, 9(2), 255-269. doi: 10.1586/14737175.9.2.255 PMID: 19210199
  47. Baxter, L.R., Jr; Schwartz, J.M.; Bergman, K.S.; Szuba, M.P.; Guze, B.H.; Mazziotta, J.C.; Alazraki, A.; Selin, C.E.; Ferng, H.K.; Munford, P. Caudate glucose metabolic rate changes with both drug and behavior therapy for obsessive-compulsive disorder. Arch. Gen. Psychiatry, 1992, 49(9), 681-689. doi: 10.1001/archpsyc.1992.01820090009002 PMID: 1514872
  48. Chamberlain, S.R.; Menzies, L.; Hampshire, A.; Suckling, J.; Fineberg, N.A.; del Campo, N.; Aitken, M.; Craig, K.; Owen, A.M.; Bullmore, E.T.; Robbins, T.W.; Sahakian, B.J. Orbitofrontal dysfunction in patients with obsessive-compulsive disorder and their unaffected relatives. Science, 2008, 321(5887), 421-422. doi: 10.1126/science.1154433 PMID: 18635808
  49. Maia, T.V.; Cooney, R.E.; Peterson, B.S. The neural bases of obsessive–compulsive disorder in children and adults. Dev. Psychopathol., 2008, 20(4), 1251-1283. doi: 10.1017/S0954579408000606 PMID: 18838041
  50. Pujol, J.; Soriano-Mas, C.; Alonso, P.; Cardoner, N.; Menchón, J.M.; Deus, J.; Vallejo, J. Mapping structural brain alterations in obsessive-compulsive disorder. Arch. Gen. Psychiatry, 2004, 61(7), 720-730. doi: 10.1001/archpsyc.61.7.720 PMID: 15237084
  51. Saxena, S.; Bota, R.G.; Brody, A.L. Brain-behavior relationships in obsessive-compulsive disorder. Semin. Clin. Neuropsychiatry, 2001, 6(2), 82-101. doi: 10.1053/scnp.2001.21833 PMID: 11296309
  52. Saxena, S.; Brody, A.L.; Schwartz, J.M.; Baxter, L.R. Neuroimaging and frontal-subcortical circuitry in obsessive-compulsive disorder. Br. J. Psychiatry, 1998, 173(S35), 26-37. doi: 10.1192/S0007125000297870 PMID: 9829024
  53. Saxena, S.; Rauch, S.L. Functional neuroimaging and the neuroanatomy of obsessive-compulsive disorder. Psychiatr. Clin. North Am., 2000, 23(3), 563-586. doi: 10.1016/S0193-953X(05)70181-7 PMID: 10986728
  54. van den Heuvel, O.A.; Veltman, D.J.; Groenewegen, H.J.; Cath, D.C.; van Balkom, A.J.L.M.; van Hartskamp, J.; Barkhof, F.; van Dyck, R. Frontal-striatal dysfunction during planning in obsessive-compulsive disorder. Arch. Gen. Psychiatry, 2005, 62(3), 301-309. doi: 10.1001/archpsyc.62.3.301 PMID: 15753243
  55. Heuvel, O.A.; Boedhoe, P.S.W.; Bertolin, S.; Bruin, W.B.; Francks, C.; Ivanov, I.; Jahanshad, N.; Kong, X.Z.; Kwon, J.S.; O’Neill, J.; Paus, T.; Patel, Y.; Piras, F.; Schmaal, L.; Soriano-Mas, C.; Spalletta, G.; Wingen, G.A.; Yun, J.Y.; Vriend, C.; Simpson, H.B.; Rooij, D.; Hoexter, M.Q.; Hoogman, M.; Buitelaar, J.K.; Arnold, P.; Beucke, J.C.; Benedetti, F.; Bollettini, I.; Bose, A.; Brennan, B.P.; De Nadai, A.S.; Fitzgerald, K.; Gruner, P.; Grünblatt, E.; Hirano, Y.; Huyser, C.; James, A.; Koch, K.; Kvale, G.; Lazaro, L.; Lochner, C.; Marsh, R.; Mataix-Cols, D.; Morgado, P.; Nakamae, T.; Nakao, T.; Narayanaswamy, J.C.; Nurmi, E.; Pittenger, C.; Reddy, Y.C.J.; Sato, J.R.; Soreni, N.; Stewart, S.E.; Taylor, S.F.; Tolin, D.; Thomopoulos, S.I.; Veltman, D.J.; Venkatasubramanian, G.; Walitza, S.; Wang, Z.; Thompson, P.M.; Stein, D.J.; Abe, Y.; Alonso, P.; Assogna, F.; Banaj, N.; Batistuzzo, M.C.; Brem, S.; Ciullo, V.; Feusner, J.; Martínez-Zalacaín, I.; Menchón, J.M.; Miguel, E.C.; Piacentini, J.; Piras, F.; Sakai, Y.; Wolters, L.; Yamada, K. An overview of the first 5 years of the ENIGMA obsessive–compulsive disorder working group: The power of worldwide collaboration. Hum. Brain Mapp., 2022, 43(1), 23-36. doi: 10.1002/hbm.24972 PMID: 32154629
  56. Bu, X.; Hu, X.; Zhang, L.; Li, B.; Zhou, M.; Lu, L.; Hu, X.; Li, H.; Yang, Y.; Tang, W.; Gong, Q.; Huang, X. Investigating the predictive value of different resting-state functional MRI parameters in obsessive-compulsive disorder. Transl. Psychiatry, 2019, 9(1), 17. doi: 10.1038/s41398-018-0362-9 PMID: 30655506
  57. Narayanaswamy, J.C.; Hazari, N.; Venkatasubramanian, G. Neuroimaging findings in obsessive–compulsive disorder: A narrative review to elucidate neurobiological underpinnings. Indian J. Psychiatry, 2019, 61(7)(Suppl. 1), 9. doi: 10.4103/psychiatry.IndianJPsychiatry_525_18 PMID: 30745673
  58. Tian, L.; Meng, C.; Jiang, Y.; Tang, Q.; Wang, S.; Xie, X.; Fu, X.; Jin, C.; Zhang, F.; Wang, J. Abnormal functional connectivity of brain network hubs associated with symptom severity in treatment-naive patients with obsessive–compulsive disorder: A resting-state functional MRI study. Prog. Neuropsychopharmacol. Biol. Psychiatry, 2016, 66, 104-111. doi: 10.1016/j.pnpbp.2015.12.003 PMID: 26683173
  59. Gürsel, D.A.; Avram, M.; Sorg, C.; Brandl, F.; Koch, K. Frontoparietal areas link impairments of large-scale intrinsic brain networks with aberrant fronto-striatal interactions in OCD: a meta-analysis of resting-state functional connectivity. Neurosci. Biobehav. Rev., 2018, 87, 151-160. doi: 10.1016/j.neubiorev.2018.01.016 PMID: 29410103
  60. Gonçalves, Ó.F.; Soares, J.M.; Carvalho, S.; Leite, J.; Ganho-Ávila, A.; Fernandes-Gonçalves, A.; Pocinho, F.; Carracedo, A.; Sampaio, A. Patterns of default mode network deactivation in obsessive compulsive disorder. Sci. Rep., 2017, 7(1), 44468. doi: 10.1038/srep44468 PMID: 28287615
  61. Stern, E.R.; Fitzgerald, K.D.; Welsh, R.C.; Abelson, J.L.; Taylor, S.F. Resting-state functional connectivity between fronto-parietal and default mode networks in obsessive-compulsive disorder. PLoS One, 2012, 7(5), e36356. doi: 10.1371/journal.pone.0036356 PMID: 22570705
  62. Hansen, E.S.; Hasselbalch, S.; Law, I.; Bolwig, T.G. The caudate nucleus in obsessive–compulsive disorder. Reduced metabolism following treatment with paroxetine: a PET study. Int. J. Neuropsychopharmacol., 2002, 5(1), 1-10. doi: 10.1017/S1461145701002681 PMID: 12057027
  63. Perani, D.; Colombo, C.; Bressi, S.; Bonfanti, A.; Grassi, F.; Scarone, S.; Bellodi, L.; Smeraldi, E.; Fazio, F. 18FFDG PET study in obsessive-compulsive disorder. A clinical/metabolic correlation study after treatment. Br. J. Psychiatry, 1995, 166(2), 244-250. doi: 10.1192/bjp.166.2.244 PMID: 7728370
  64. Saxena, S.; Brody, A.L.; Maidment, K.M.; Dunkin, J.J.; Colgan, M.; Alborzian, S. Localized orbitofrontal and subcortical metabolic changes and predictors of response to paroxetine treatment in obsessive-compulsive disorder. Neuropsychopharmacology, 1999, 21(6), 683-693.
  65. Gerentes, M.; Pelissolo, A.; Rajagopal, K.; Tamouza, R.; Hamdani, N. Obsessive-compulsive disorder. Autoimmunity and Neuroinflammation. Curr. Psychiatry Rep., 2019, 21(8), 78. doi: 10.1007/s11920-019-1062-8 PMID: 31367805
  66. Attwells, S.; Setiawan, E.; Wilson, A.A.; Rusjan, P.M.; Mizrahi, R.; Miler, L.; Xu, C.; Richter, M.A.; Kahn, A.; Kish, S.J.; Houle, S.; Ravindran, L.; Meyer, J.H. Inflammation in the neurocircuitry of obsessive-compulsive disorder. JAMA Psychiatry, 2017, 74(8), 833-840. doi: 10.1001/jamapsychiatry.2017.1567 PMID: 28636705
  67. Turna, J.; Grosman Kaplan, K.; Anglin, R.; Van Ameringen, M. "What’s bugging the gut in OCD?" A review of the gut microbiome in obsessive-compulsive disorder. Depress. Anxiety, 2016, 33(3), 171-178. doi: 10.1002/da.22454 PMID: 26629974
  68. Renna, M.E.; O’Toole, M.S.; Spaeth, P.E.; Lekander, M.; Mennin, D.S. The association between anxiety, traumatic stress, and obsessive-compulsive disorders and chronic inflammation: A systematic review and meta-analysis. Depress. Anxiety, 2018, 35(11), 1081-1094. doi: 10.1002/da.22790 PMID: 30199144
  69. Lewis, D.A. The human brain revisited: Opportunities and challenges in postmortem studies of psychiatric disorders. Neuropsychopharmacology, 2002, 26(2), 143-154.
  70. de Lange, G.M. Understanding the cellular and molecular alterations in PTSD brains: The necessity of post-mortem brain tissue. Eur. J. Psychotraumatol., 2017, 8(1), 1341824. doi: 10.1080/20008198.2017.1341824 PMID: 28680541
  71. Page, M.J.; McKenzie, J.E.; Bossuyt, P.M.; Boutron, I.; Hoffmann, T.C.; Mulrow, C.D.; Shamseer, L.; Tetzlaff, J.M.; Akl, E.A.; Brennan, S.E.; Chou, R.; Glanville, J.; Grimshaw, J.M.; Hróbjartsson, A.; Lalu, M.M.; Li, T.; Loder, E.W.; Mayo-Wilson, E.; McDonald, S.; McGuinness, L.A.; Stewart, L.A.; Thomas, J.; Tricco, A.C.; Welch, V.A.; Whiting, P.; Moher, D. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ, 2021, 372(71), n71. doi: 10.1136/bmj.n71 PMID: 33782057
  72. Downes, M.J.; Brennan, M.L.; Williams, H.C.; Dean, R.S. Development of a critical appraisal tool to assess the quality of cross-sectional studies (AXIS). BMJ Open, 2016, 6(12), e011458. doi: 10.1136/bmjopen-2016-011458 PMID: 27932337
  73. Jaffe, A.E.; Deep-Soboslay, A.; Tao, R.; Hauptman, D.T.; Kaye, W.H.; Arango, V.; Weinberger, D.R.; Hyde, T.M.; Kleinman, J.E. Genetic neuropathology of obsessive psychiatric syndromes. Transl. Psychiatry, 2014, 4(9), e432. doi: 10.1038/tp.2014.68 PMID: 25180571
  74. Lipska, B.K.; Deep-Soboslay, A.; Weickert, C.S.; Hyde, T.M.; Martin, C.E.; Herman, M.M.; Kleinman, J.E. Critical factors in gene expression in postmortem human brain: Focus on studies in schizophrenia. Biol. Psychiatry, 2006, 60(6), 650-658. doi: 10.1016/j.biopsych.2006.06.019 PMID: 16997002
  75. Ruden, J.B.; Dugan, L.L.; Konradi, C. Parvalbumin interneuron vulnerability and brain disorders. Neuropsychopharmacology, 2021, 46(2), 279-287. doi: 10.1038/s41386-020-0778-9
  76. Hoseth, E.Z.; Krull, F.; Dieset, I.; Mørch, R.H.; Hope, S.; Gardsjord, E.S.; Steen, N.E.; Melle, I.; Brattbakk, H.R.; Steen, V.M.; Aukrust, P.; Djurovic, S.; Andreassen, O.A.; Ueland, T. Attenuated Notch signaling in schizophrenia and bipolar disorder. Sci. Rep., 2018, 8(1), 5349. doi: 10.1038/s41598-018-23703-w PMID: 29593239
  77. de Oliveira, K.C.; Grinberg, L.T.; Hoexter, M.Q.; Brentani, H.; Suemoto, C.K.; Nery, F.G.; Lima, L.C.; Alho, A.T.D.L.; Farfel, J.M.; Ferretti-Rebustini, R.E.L.; Leite, R.E.P.; Moretto, A.C.; da Silva, A.V.; Lafer, B.; Miguel, E.C.; Nitrini, R.; Jacob-Filho, W.; Heinsen, H.; Pasqualucci, C.A. Layer-specific reduced neuronal density in the orbitofrontal cortex of older adults with obsessive–compulsive disorder. Brain Struct. Funct., 2019, 224(1), 191-203. doi: 10.1007/s00429-018-1752-8 PMID: 30298291
  78. Hoexter, M.Q.; Diniz, J.B.; Lopes, A.C.; Batistuzzo, M.C.; Shavitt, R.G.; Dougherty, D.D.; Duran, F.L.S.; Bressan, R.A.; Busatto, G.F.; Miguel, E.C.; Sato, J.R. Orbitofrontal thickness as a neasure for treatment response prediction in obsessive-compulsive disorder. Depress. Anxiety, 2015, 32(12), 900-908. doi: 10.1002/da.22380 PMID: 26032588
  79. Christian, C.J.; Lencz, T.; Robinson, D.G.; Burdick, K.E.; Ashtari, M.; Malhotra, A.K.; Betensky, J.D.; Szeszko, P.R. Gray matter structural alterations in obsessive–compulsive disorder: Relationship to neuropsychological functions. Psychiatry Res. Neuroimaging, 2008, 164(2), 123-131. doi: 10.1016/j.pscychresns.2008.03.005 PMID: 18938065
  80. Kim, J.J.; Lee, M.C.; Kim, J.; Kim, I.Y.; Kim, S.I.; Han, M.H.; Chang, K.H.; Kwon, J.S. Grey matter abnormalities in obsessive–compulsive disorder. Br. J. Psychiatry, 2001, 179(4), 330-334. doi: 10.1192/bjp.179.4.330 PMID: 11581113
  81. Valente, A.A., Jr; Miguel, E.C.; Castro, C.C.; Amaro, E., Jr; Duran, F.L.S.; Buchpiguel, C.A.; Chitnis, X.; McGuire, P.K.; Busatto, G.F. Regional gray matter abnormalities in obsessive-compulsive disorder: A voxel-based morphometry study. Biol. Psychiatry, 2005, 58(6), 479-487. doi: 10.1016/j.biopsych.2005.04.021 PMID: 15978549
  82. Hoexter, M.Q.; de Souza Duran, F.L.; D’Alcante, C.C.; Dougherty, D.D.; Shavitt, R.G.; Lopes, A.C. Gray matter volumes in obsessive-compulsive disorder before and after fluoxetine or cognitive-behavior therapy: A randomized clinical trial. Neuropsychopharmacology, 2012, 37(3), 45.
  83. Rotge, J-Y.; Langbour, N.; Guehl, D.; Bioulac, B.; Jaafari, N.; Allard, M. Gray matter alterations in obsessive-compulsive disorder: An anatomic likelihood estimation meta-analysis. Neuropsychopharmacology, 2010, 35(3), 686-691.
  84. Szeszko, P.R.; Robinson, D.; Alvir, J.M.J.; Bilder, R.M.; Lencz, T.; Ashtari, M.; Wu, H.; Bogerts, B. Orbital frontal and amygdala volume reductions in obsessive-compulsive disorder. Arch. Gen. Psychiatry, 1999, 56(10), 913-919. doi: 10.1001/archpsyc.56.10.913 PMID: 10530633
  85. Togao, O.; Yoshiura, T.; Nakao, T.; Nabeyama, M.; Sanematsu, H.; Nakagawa, A.; Noguchi, T.; Hiwatashi, A.; Yamashita, K.; Nagao, E.; Kanba, S.; Honda, H. Regional gray and white matter volume abnormalities in obsessive–compulsive disorder: A voxel-based morphometry study. Psychiatry Res. Neuroimaging, 2010, 184(1), 29-37. doi: 10.1016/j.pscychresns.2010.06.011 PMID: 20833001
  86. Yoo, S.Y.; Roh, M.S.; Choi, J.S.; Kang, D.H.; Ha, T.H.; Lee, J.M.; Kim, I.Y.; Kim, S.I.; Kwon, J.S. Voxel-based morphometry study of gray matter abnormalities in obsessive-compulsive disorder. J. Korean Med. Sci., 2008, 23(1), 24-30. doi: 10.3346/jkms.2008.23.1.24 PMID: 18303194
  87. Gillan, C.M.; Apergis-Schoute, A.M.; Morein-Zamir, S.; Urcelay, G.P.; Sule, A.; Fineberg, N.A.; Sahakian, B.J.; Robbins, T.W. Functional neuroimaging of avoidance habits in obsessive-compulsive disorder. Am. J. Psychiatry, 2015, 172(3), 284-293. doi: 10.1176/appi.ajp.2014.14040525 PMID: 25526600
  88. Harrison, B.J.; Pujol, J.; Soriano-Mas, C.; Hernández-Ribas, R.; López-Solà, M.; Ortiz, H.; Alonso, P.; Deus, J.; Menchon, J.M.; Real, E.; Segalàs, C.; Contreras-Rodríguez, O.; Blanco-Hinojo, L.; Cardoner, N. Neural correlates of moral sensitivity in obsessive-compulsive disorder. Arch. Gen. Psychiatry, 2012, 69(7), 741-749. doi: 10.1001/archgenpsychiatry.2011.2165 PMID: 22752238
  89. Maltby, N.; Tolin, D.F.; Worhunsky, P.; O’Keefe, T.M.; Kiehl, K.A. Dysfunctional action monitoring hyperactivates frontal–striatal circuits in obsessive–compulsive disorder: an event-related fMRI study. Neuroimage, 2005, 24(2), 495-503. doi: 10.1016/j.neuroimage.2004.08.041 PMID: 15627591
  90. Radua, J.; Mataix-Cols, D. Voxel-wise meta-analysis of grey matter changes in obsessive–compulsive disorder. Br. J. Psychiatry, 2009, 195(5), 393-402. doi: 10.1192/bjp.bp.108.055046 PMID: 19880927
  91. Lisboa, B.C.G.; Oliveira, K.C.; Tahira, A.C.; Barbosa, A.R.; Feltrin, A.S.A.; Gouveia, G.; Lima, L.; Feio dos Santos, A.C.; Martins, D.C., Jr; Puga, R.D.; Moretto, A.C.; De Bragança Pereira, C.A.; Lafer, B.; Leite, R.E.P.; Ferretti-Rebustini, R.E.D.L.; Farfel, J.M.; Grinberg, L.T.; Jacob-Filho, W.; Miguel, E.C.; Hoexter, M.Q.; Brentani, H. Initial findings of striatum tripartite model in OCD brain samples based on transcriptome analysis. Sci. Rep., 2019, 9(1), 3086. doi: 10.1038/s41598-019-38965-1 PMID: 30816141
  92. Milad, M.R.; Pitman, R.K.; Ellis, C.B.; Gold, A.L.; Shin, L.M.; Lasko, N.B.; Zeidan, M.A.; Handwerger, K.; Orr, S.P.; Rauch, S.L. Neurobiological basis of failure to recall extinction memory in posttraumatic stress disorder. Biol. Psychiatry, 2009, 66(12), 1075-1082. doi: 10.1016/j.biopsych.2009.06.026 PMID: 19748076
  93. Milad, M.R.; Rauch, S.L. Obsessive-compulsive disorder: beyond segregated cortico-striatal pathways. Trends Cogn. Sci., 2012, 16(1), 43-51. doi: 10.1016/j.tics.2011.11.003 PMID: 22138231
  94. Tschernegg, M.; Pletzer, B.; Schwartenbeck, P.; Ludersdorfer, P.; Hoffmann, U.; Kronbichler, M. Impulsivity relates to striatal gray matter volumes in humans: evidence from a delay discounting paradigm. Front. Hum. Neurosci., 2015, 9, 384. doi: 10.3389/fnhum.2015.00384 PMID: 26190993
  95. Piras, F.; Piras, F.; Chiapponi, C.; Girardi, P.; Caltagirone, C.; Spalletta, G. Widespread structural brain changes in OCD: A systematic review of voxel-based morphometry studies. Cortex, 2015, 62, 89-108. doi: 10.1016/j.cortex.2013.01.016 PMID: 23582297
  96. Parkes, L.; Fulcher, B.D.; Yücel, M.; Fornito, A. Transcriptional signatures of connectomic subregions of the human striatum. Genes Brain Behav., 2017, 16(7), 647-663. doi: 10.1111/gbb.12386 PMID: 28421658
  97. de Oliveira, K.C.; Camilo, C.; Gastaldi, V.D.; Sant’Anna Feltrin, A.; Lisboa, B.C.G.; de Jesus Rodrigues de Paula, V. Brain areas involved with obsessive-compulsive disorder present different DNA methylation modulation. BMC genomic data, 2021, 22(1), 45.
  98. Yue, W.; Cheng, W.; Liu, Z.; Tang, Y.; Lu, T.; Zhang, D.; Tang, M.; Huang, Y. Genome-wide DNA methylation analysis in obsessive-compulsive disorder patients. Sci. Rep., 2016, 6(1), 31333. doi: 10.1038/srep31333 PMID: 27527274
  99. Nissen, J.B.; Hansen, C.S.; Starnawska, A.; Mattheisen, M.; Børglum, A.D.; Buttenschøn, H.N.; Hollegaard, M. DNA Methylation at the neonatal state and at the time of diagnosis: Preliminary support for an association with the estrogen receptor 1, gamma-aminobutyric acid B receptor 1, and myelin oligodendrocyte glycoprotein in female adolescent patients with OCD. Front. Psychiatry, 2016, 7, 35. doi: 10.3389/fpsyt.2016.00035 PMID: 27047397
  100. Cappi, C.; Diniz, J.B.; Requena, G.L.; Lourenço, T.; Lisboa, B.C.G.; Batistuzzo, M.C.; Marques, A.H.; Hoexter, M.Q.; Pereira, C.A.; Miguel, E.C.; Brentani, H. Epigenetic evidence for involvement of the oxytocin receptor gene in obsessive–compulsive disorder. BMC Neurosci., 2016, 17(1), 79. doi: 10.1186/s12868-016-0313-4 PMID: 27903255
  101. D’Addario, C.; Bellia, F.; Benatti, B.; Grancini, B.; Vismara, M.; Pucci, M.; De Carlo, V.; Viganò, C.; Galimberti, D.; Fenoglio, C.; Scarpini, E.; Maccarrone, M.; Dell’Osso, B. Exploring the role of BDNF DNA methylation and hydroxymethylation in patients with obsessive compulsive disorder. J. Psychiatr. Res., 2019, 114, 17-23. doi: 10.1016/j.jpsychires.2019.04.006 PMID: 31004918
  102. Grünblatt, E.; Marinova, Z.; Roth, A.; Gardini, E.; Ball, J.; Geissler, J.; Wojdacz, T.K.; Romanos, M.; Walitza, S. Combining genetic and epigenetic parameters of the serotonin transporter gene in obsessive-compulsive disorder. J. Psychiatr. Res., 2018, 96, 209-217. doi: 10.1016/j.jpsychires.2017.10.010 PMID: 29102815
  103. Horvath, S. DNA methylation age of human tissues and cell types. Genome Biol., 2013, 14(10), R115. doi: 10.1186/gb-2013-14-10-r115 PMID: 24138928
  104. Marazziti, D.; Mucci, F.; Fontenelle, L.F. Immune system and obsessive-compulsive disorder. Psychoneuroendocrinology, 2018, 93, 39-44. doi: 10.1016/j.psyneuen.2018.04.013 PMID: 29689421
  105. Rodriguez, N.; Morer, A.; González-Navarro, E.A.; Gassó, P.; Boloc, D.; Serra-Pagès, C. Human-leukocyte antigen class II genes in early-onset obsessive-compulsive disorder. World J. Biol. Psychiatry, 2019, 20(5), 352-358.
  106. Piantadosi, S.C.; Chamberlain, B.L.; Glausier, J.R.; Lewis, D.A.; Ahmari, S.E. Lower excitatory synaptic gene expression in orbitofrontal cortex and striatum in an initial study of subjects with obsessive compulsive disorder. Mol. Psychiatry, 2021, 26(3), 986-998. doi: 10.1038/s41380-019-0431-3 PMID: 31168067
  107. Harrison, B.J.; Soriano-Mas, C.; Pujol, J.; Ortiz, H.; López-Solà, M.; Hernández-Ribas, R.; Deus, J.; Alonso, P.; Yücel, M.; Pantelis, C.; Menchon, J.M.; Cardoner, N. Altered corticostriatal functional connectivity in obsessive-compulsive disorder. Arch. Gen. Psychiatry, 2009, 66(11), 1189-1200. doi: 10.1001/archgenpsychiatry.2009.152 PMID: 19884607
  108. Menzies, L.; Achard, S.; Chamberlain, S.R.; Fineberg, N.; Chen, C.H.; del Campo, N.; Sahakian, B.J.; Robbins, T.W.; Bullmore, E. Neurocognitive endophenotypes of obsessive-compulsive disorder. Brain, 2007, 130(12), 3223-3236. doi: 10.1093/brain/awm205 PMID: 17855376
  109. Menzies, L.; Chamberlain, S.R.; Laird, A.R.; Thelen, S.M.; Sahakian, B.J.; Bullmore, E.T. Integrating evidence from neuroimaging and neuropsychological studies of obsessive-compulsive disorder: The orbitofronto-striatal model revisited. Neurosci. Biobehav. Rev., 2008, 32(3), 525-549. doi: 10.1016/j.neubiorev.2007.09.005 PMID: 18061263
  110. Rauch, S.L.; Savage, C.R.; Alpert, N.M.; Dougherty, D.; Kendrick, A.; Curran, T.; Brown, H.D.; Manzo, P.; Fischman, A.J.; Jenike, M.A. Probing striatal function in obsessive-compulsive disorder: a PET study of implicit sequence learning. J. Neuropsychiatry Clin. Neurosci., 1997, 9(4), 568-573. doi: 10.1176/jnp.9.4.568 PMID: 9447498
  111. Rotge, J.Y.; Guehl, D.; Dilharreguy, B.; Tignol, J.; Bioulac, B.; Allard, M.; Burbaud, P.; Aouizerate, B. Meta-analysis of brain volume changes in obsessive-compulsive disorder. Biol. Psychiatry, 2009, 65(1), 75-83. doi: 10.1016/j.biopsych.2008.06.019 PMID: 18718575
  112. Piantadosi, S.C.; McClain, L.L.; Klei, L.; Wang, J.; Chamberlain, B.L.; Springer, S.A.; Lewis, D.A.; Devlin, B.; Ahmari, S.E. Transcriptome alterations are enriched for synapse-associated genes in the striatum of subjects with obsessive-compulsive disorder. Transl. Psychiatry, 2021, 11(1), 171. doi: 10.1038/s41398-021-01290-1 PMID: 33723209
  113. First, M.B.; Spitzer, R.L.; Gobbon, M.; Williams, J.B.W. Structured clinical interview for DSM-IV Axis I disorders - Patient edition; New York State Psychiatric Institute, Biometrics Research Department: New York, 1998.
  114. Goodman, W.K.; Price, L.H.; Rasmussen, S.A.; Mazure, C.; Fleischmann, R.L.; Hill, C.L.; Heninger, G.R.; Charney, D.S. The Yale-Brown obsessive-compulsive scale: I. Development, use, and reliability. Arch. Gen. Psychiatry, 1989, 46(11), 1006-1011. doi: 10.1001/archpsyc.1989.01810110048007 PMID: 2684084
  115. Harrison, P.J. Using our brains: the findings, flaws, and future of postmortem studies of psychiatric disorders. Biol. Psychiatry, 2011, 69(2), 102-103.
  116. Sidorchuk, A.; Kuja-Halkola, R.; Runeson, B.; Lichtenstein, P.; Larsson, H.; Rück, C.; D’Onofrio, B.M.; Mataix-Cols, D.; Fernández de la Cruz, L. Genetic and environmental sources of familial coaggregation of obsessive-compulsive disorder and suicidal behavior: a population-based birth cohort and family study. Mol. Psychiatry, 2021, 26(3), 974-985. doi: 10.1038/s41380-019-0417-1 PMID: 30962511
  117. McCullumsmith, R.E.; Hammond, J.H.; Shan, D.; Meador-Woodruff, J.H. Postmortem brain: an underutilized substrate for studying severe mental illness. Neuropsychopharmacology, 2014, 39(1), 65-87.
  118. Vidal-Ribas, P.; Stringaris, A.; Rück, C.; Serlachius, E.; Lichtenstein, P.; Mataix-Cols, D. Are stressful life events causally related to the severity of obsessive-compulsive symptoms? A monozygotic twin difference study. Eur. Psychiatry, 2015, 30(2), 309-316.
  119. Murayama, K.; Nakao, T.; Ohno, A.; Tsuruta, S.; Tomiyama, H.; Hasuzawa, S.; Mizobe, T.; Kato, K.; Kanba, S. Impacts of stressful life events and traumatic experiences on onset of obsessive-compulsive disorder. Front. Psychiatry, 2020, 11, 561266. doi: 10.3389/fpsyt.2020.561266 PMID: 33343411
  120. Rademaker, M.C.; de Lange, G.M.; Palmen, S.J.M.C. The Netherlands Brain Bank for Psychiatry. Handb. Clin. Neurol., 2018, 150, 3-16. doi: 10.1016/B978-0-444-63639-3.00001-3 PMID: 29496148
  121. Ikonomovic, M.D.; Buckley, C.J.; Heurling, K.; Sherwin, P.; Jones, P.A.; Zanette, M.; Mathis, C.A.; Klunk, W.E.; Chakrabarty, A.; Ironside, J.; Ismail, A.; Smith, C.; Thal, D.R.; Beach, T.G.; Farrar, G.; Smith, A.P.L. Post-mortem histopathology underlying β-amyloid PET imaging following flutemetamol F 18 injection. Acta Neuropathol. Commun., 2016, 4(1), 130. doi: 10.1186/s40478-016-0399-z PMID: 27955679
  122. Yendiki, A.; Aggarwal, M.; Axer, M.; Howard, A.F.D.; van Walsum, A.M.C.; Haber, S.N. Post mortem mapping of connectional anatomy for the validation of diffusion MRI. Neuroimage, 2022, 256, 119146. doi: 10.1016/j.neuroimage.2022.119146 PMID: 35346838
  123. de Oliveira, K.C.; Nery, F.G.; Ferreti, R.E.L.; Lima, M.C.; Cappi, C.; Machado-Lima, A.; Polichiso, L.; Carreira, L.L.; Ávila, C.; Alho, A.T.D.L.; Brentani, H.P.; Miguel, E.C.; Heinsen, H.; Jacob-Filho, W.; Pasqualucci, C.A.; Lafer, B.; Grinberg, L.T. Brazilian psychiatric brain bank: A new contribution tool to network studies. Cell Tissue Bank., 2012, 13(2), 315-326. doi: 10.1007/s10561-011-9258-0 PMID: 21562728
  124. de Lange, G.M.; Rademaker, M.; Boks, M.P.; Palmen, S.J.M.C. Brain donation in psychiatry: results of a Dutch prospective donor program among psychiatric cohort participants. BMC Psychiatry, 2017, 17(1), 347. doi: 10.1186/s12888-017-1513-x PMID: 29058593

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2024 Bentham Science Publishers